An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments

Jenifer Vohs, Sunita George, Bethany L. Leonhardt, Paul H. Lysaker

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Introduction: Poor insight, or unawareness of some major aspect of mental illness, is a major barrier to wellness when it interferes with persons seeking out treatment or forming their own understanding of the challenges they face. One barrier to addressing impaired insight is the absence of a comprehensive model of how poor insight develops. Areas covered: To explore this issue we review how poor insight is the result of multiple phenomena which interfere with the construction of narrative accounts of psychiatric challenges, rather than a single social or biological cause. Expert commentary: We propose an integrative model of poor insight in schizophrenia which involves the interaction of symptoms, deficits in neurocognition, social cognition, metacognition, and stigma. Emerging treatments for poor insight including therapies which focus on the development of metacognition are discussed.

Original languageEnglish (US)
Pages (from-to)1193-1204
Number of pages12
JournalExpert Review of Neurotherapeutics
Volume16
Issue number10
DOIs
StatePublished - Oct 2 2016

Fingerprint

Schizophrenia
Research
Cognition
Psychiatry
Metacognition
Therapeutics

Keywords

  • insight
  • metacognition
  • neurocognition
  • Schizophrenia
  • social cognition
  • stigma
  • symptoms

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

An integrative model of the impairments in insight in schizophrenia : emerging research on causal factors and treatments. / Vohs, Jenifer; George, Sunita; Leonhardt, Bethany L.; Lysaker, Paul H.

In: Expert Review of Neurotherapeutics, Vol. 16, No. 10, 02.10.2016, p. 1193-1204.

Research output: Contribution to journalReview article

@article{2a68af2afc06402cad218f6e9fd883b6,
title = "An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments",
abstract = "Introduction: Poor insight, or unawareness of some major aspect of mental illness, is a major barrier to wellness when it interferes with persons seeking out treatment or forming their own understanding of the challenges they face. One barrier to addressing impaired insight is the absence of a comprehensive model of how poor insight develops. Areas covered: To explore this issue we review how poor insight is the result of multiple phenomena which interfere with the construction of narrative accounts of psychiatric challenges, rather than a single social or biological cause. Expert commentary: We propose an integrative model of poor insight in schizophrenia which involves the interaction of symptoms, deficits in neurocognition, social cognition, metacognition, and stigma. Emerging treatments for poor insight including therapies which focus on the development of metacognition are discussed.",
keywords = "insight, metacognition, neurocognition, Schizophrenia, social cognition, stigma, symptoms",
author = "Jenifer Vohs and Sunita George and Leonhardt, {Bethany L.} and Lysaker, {Paul H.}",
year = "2016",
month = "10",
day = "2",
doi = "10.1080/14737175.2016.1199275",
language = "English (US)",
volume = "16",
pages = "1193--1204",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "10",

}

TY - JOUR

T1 - An integrative model of the impairments in insight in schizophrenia

T2 - emerging research on causal factors and treatments

AU - Vohs, Jenifer

AU - George, Sunita

AU - Leonhardt, Bethany L.

AU - Lysaker, Paul H.

PY - 2016/10/2

Y1 - 2016/10/2

N2 - Introduction: Poor insight, or unawareness of some major aspect of mental illness, is a major barrier to wellness when it interferes with persons seeking out treatment or forming their own understanding of the challenges they face. One barrier to addressing impaired insight is the absence of a comprehensive model of how poor insight develops. Areas covered: To explore this issue we review how poor insight is the result of multiple phenomena which interfere with the construction of narrative accounts of psychiatric challenges, rather than a single social or biological cause. Expert commentary: We propose an integrative model of poor insight in schizophrenia which involves the interaction of symptoms, deficits in neurocognition, social cognition, metacognition, and stigma. Emerging treatments for poor insight including therapies which focus on the development of metacognition are discussed.

AB - Introduction: Poor insight, or unawareness of some major aspect of mental illness, is a major barrier to wellness when it interferes with persons seeking out treatment or forming their own understanding of the challenges they face. One barrier to addressing impaired insight is the absence of a comprehensive model of how poor insight develops. Areas covered: To explore this issue we review how poor insight is the result of multiple phenomena which interfere with the construction of narrative accounts of psychiatric challenges, rather than a single social or biological cause. Expert commentary: We propose an integrative model of poor insight in schizophrenia which involves the interaction of symptoms, deficits in neurocognition, social cognition, metacognition, and stigma. Emerging treatments for poor insight including therapies which focus on the development of metacognition are discussed.

KW - insight

KW - metacognition

KW - neurocognition

KW - Schizophrenia

KW - social cognition

KW - stigma

KW - symptoms

UR - http://www.scopus.com/inward/record.url?scp=84987973350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987973350&partnerID=8YFLogxK

U2 - 10.1080/14737175.2016.1199275

DO - 10.1080/14737175.2016.1199275

M3 - Review article

C2 - 27278672

AN - SCOPUS:84987973350

VL - 16

SP - 1193

EP - 1204

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 10

ER -